August 15, 2023: Frontage Laboratories, Inc. and its wholly-owned subsidiary, Frontage Canada, Inc., completed the acquisition of Nucro-Technics Inc. and its affiliate Nucro-Technics Holdings, Inc. Nucro-Technics is a pharmaceutical contract research organization that conducts analytical chemistry, microbiology, toxicology, bioanalytical, and stability sample storage and testing services. In addition, it provides consulting services, especially in [...]

As with every year in March, five thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the Society of Toxicology ToxExpo Meeting / Conference. These attendees are there to attend more than 2,000 presentations and meet with more than 250 exhibitors throughout Canada, the United States, [...]

The COVID-19 pandemic is serious and affects us all. Nucro-Technics is a business that has been deemed an essential service. Put simply, as part of our routine activities, the testing that we do allows for drugs to be released into the market. These are drugs that are being used to help treat people with the [...]

Nucro-Technics is very pleased to announce that it has been approved by the Eurostars program as part of a consortium led by Addex Therapeutics. The project, named DiSARM FEAR, is for the development of a novel allosteric modulator to treat post-traumatic stress disorder (PTSD). This venture involves an international group of companies that span [...]

As with every year in June, twenty thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the BIO Conference. These attendees cover more than 1,000 biotech companies, academic institutions, regional hubs, and related organizations throughout Canada, the United States, and across the world. Nucro-Technics has been [...]